Beyond Weight Loss: The Expanding Benefits of GLP-1 Medications
by Annette Pinder Medications known as GLP-1 receptor agonists—such as semaglutide and...
Read MoreCategory: Clinical Research
Mechanism‑Driven Strategy for Targeting p53‑Mutant Cancers
Two‑step approach reveals a fundamental vulnerability in one of cancer’s most common mutations New...
Read More
CAR T-Cell Therapy: Could a Cancer Breakthrough Cure Autoimmune Diseases?
Roswell Park team aims to shift patients from lifelong medications to durable, drug-free...
Read More
Survival Benefit of Immunotherapy in Resistant Ovarian Cancer
Phase 3 trial demonstrates survival benefit from immunotherapy-based regimen in platinum-resistant...
Read More
Roswell Park Debuts Exclusive CAR T-Cell Trial for Refractory AML
New treatment strategy targeting an antigen found on leukemia cells is designed to help spare...
Read More
Why Evidence-Based Autism Research Matters for Families
By Annette Pinder For families navigating an autism diagnosis, trustworthy information is...
Read More
Leucovorin and Autism: What Families Should Know
As interest grows in new and emerging autism therapies, some families are asking about...
Read More
UB Researchers’ FOXG1 Drug Cleared for Clinical Trials
UB researchers’ FOXG1 drug cleared for clinical trials Soo-Kyung and Jae Lee, whose daughter has...
Read More
Can GLP-1 Medications Benefit Heart Health?
By Annette Pinder Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of medications...
Read More
Corvia Atrial Shunt Study Offers Hope for Heart Failure Patients in Buffalo
Call 716-881-8299! You May Be Eligible! by Annette Pinder Many adults in Western New York living...
Read More
CURRENT ISSUE
SPECIAL ISSUES
